Global & US Gene Therapy Market Forecast to 2020

NEXT STORY
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PREV STORY
Generex Biotechnology Provides 2019 Year-End Summary & 2020 Plans
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ZIOPHARM Announces Publication in Scientific Reports Describing Genetic Editing of Human Leukocyte Antigen in Cell Therapies to Broaden Their Human Application

BOSTON, Feb. 23, 2016 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy

BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials

FIT Biotech Oy                                                                                                                                                                                                           Press release 27.8.2018 at 08.30 AM EET FIT Biotech ...

author_avatar
NASDAQ Market News